Works by Zinman, Bernard

Results: 424
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA‐REG OUTCOME trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 12, p. 2775, doi. 10.1111/dom.14535
    By:
    • Vaduganathan, Muthiah;
    • Inzucchi, Silvio E.;
    • Sattar, Naveed;
    • Fitchett, David H.;
    • Ofstad, Anne Pernille;
    • Brueckmann, Martina;
    • George, Jyothis T.;
    • Verma, Subodh;
    • Mattheus, Michaela;
    • Wanner, Christoph;
    • Zinman, Bernard;
    • Butler, Javed
    Publication type:
    Article
    10
    11
    12

    The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1652, doi. 10.1111/dom.14386
    By:
    • Arnott, Clare;
    • Li, Jing‐Wei;
    • Cannon, Christopher P.;
    • Zeeuw, Dick;
    • Neuen, Brendon L.;
    • Heerspink, Hiddo J. L.;
    • Charytan, David M.;
    • Agarwal, Anubha;
    • Huffman, Mark D.;
    • Figtree, Gemma A.;
    • Bakris, George;
    • Chang, Tara I‐Hsin;
    • Feng, Kent;
    • Rosenthal, Norman;
    • Zinman, Bernard;
    • Jardine, Meg J.;
    • Perkovic, Vlado;
    • Neal, Bruce;
    • Mahaffey, Kenneth W.
    Publication type:
    Article
    13
    14

    Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized CAROLINA trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 569, doi. 10.1111/dom.14254
    By:
    • Espeland, Mark A.;
    • Pratley, Richard E.;
    • Rosenstock, Julio;
    • Kadowaki, Takashi;
    • Seino, Yutaka;
    • Zinman, Bernard;
    • Marx, Nikolaus;
    • McGuire, Darren K.;
    • Andersen, Knut Robert;
    • Mattheus, Michaela;
    • Keller, Annett;
    • Weber, Maria;
    • Johansen, Odd Erik
    Publication type:
    Article
    15

    Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the LEADER and SUSTAIN 6 trials.

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2487, doi. 10.1111/dom.14160
    By:
    • Verma, Subodh;
    • McGuire, Darren K.;
    • Bain, Stephen C.;
    • Bhatt, Deepak L.;
    • Leiter, Lawrence A.;
    • Mazer, C. David;
    • Monk Fries, Tea;
    • Pratley, Richard E.;
    • Rasmussen, Søren;
    • Vrazic, Hrvoje;
    • Zinman, Bernard;
    • Buse, John B.
    Publication type:
    Article
    16
    17
    18
    19

    Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA‐REG OUTCOME trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1141, doi. 10.1111/dom.14015
    By:
    • Verma, Subodh;
    • Sharma, Abhinav;
    • Zinman, Bernard;
    • Ofstad, Anne Pernille;
    • Fitchett, David;
    • Brueckmann, Martina;
    • Wanner, Christoph;
    • Zwiener, Isabella;
    • George, Jyothis T.;
    • Inzucchi, Silvio E.;
    • Butler, Javed;
    • Mazer, C. David
    Publication type:
    Article
    20
    21
    22
    23
    24
    25

    Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7).

    Published in:
    Diabetes, Obesity & Metabolism, 2019, v. 21, n. 7, p. 1625, doi. 10.1111/dom.13699
    By:
    • Pratley, Richard E.;
    • Buse, John B.;
    • Emerson, Scott S.;
    • Franek, Edward;
    • Gilbert, Matthew P.;
    • Marso, Steven P.;
    • McGuire, Darren K.;
    • Pieber, Thomas R.;
    • Zinman, Bernard;
    • Hansen, Charlotte T.;
    • Hansen, Melissa V.;
    • Mark, Thomas;
    • Moses, Alan C.
    Publication type:
    Article
    26
    27
    28

    Day‐to‐day fasting self‐monitored blood glucose variability is associated with risk of hypoglycaemia in insulin‐treated patients with type 1 and type 2 diabetes: A post hoc analysis of the SWITCH Trials.

    Published in:
    Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 622, doi. 10.1111/dom.13565
    By:
    • DeVries, J. Hans;
    • Bailey, Timothy S.;
    • Bhargava, Anuj;
    • Gerety, Gregg;
    • Gumprecht, Janusz;
    • Heller, Simon;
    • Lane, Wendy;
    • Wysham, Carol H.;
    • Zinman, Bernard;
    • Bak, Britta A.;
    • Hachmann‐Nielsen, Elise;
    • Philis‐Tsimikas, Athena
    Publication type:
    Article
    29
    30
    31
    32
    33
    34

    Ramipril and the Development of Diabetes.

    Published in:
    JAMA: Journal of the American Medical Association, 2001, v. 286, n. 15, p. 1882, doi. 10.1001/jama.286.15.1882
    By:
    • Yusuf, Salim;
    • Gerstein, Hertzel;
    • Hoogwerf, Byron;
    • Pogue, Janice;
    • Bosch, Jackie;
    • Wolffenbuttel, Bruce H. R.;
    • Zinman, Bernard
    Publication type:
    Article
    35
    36

    Deficiencies in the Quality of Diabetes Care.

    Published in:
    JGIM: Journal of General Internal Medicine, 2007, v. 22, n. 2, p. 275, doi. 10.1007/s11606-006-0027-x
    By:
    • Shah, Baiju R.;
    • Hux, Janet E.;
    • Laupacis, Andreas;
    • Zinman, Bernard;
    • Zwarenstein, Merrick
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43

    The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial.

    Published in:
    Nephrology Dialysis Transplantation, 2020, v. 35, n. 5, p. 895, doi. 10.1093/ndt/gfz294
    By:
    • Opingari, Erika;
    • Verma, Subodh;
    • Connelly, Kim A;
    • Mazer, Cyril David;
    • Teoh, Hwee;
    • Quan, Adrian;
    • Zuo, Fei;
    • Pan, Yi;
    • Bhatt, Deepak L;
    • Zinman, Bernard;
    • Leiter, Lawrence A;
    • Yan, Andrew T;
    • Cherney, David Z I;
    • Gilbert, Richard E
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50